Ardent Health Partners, LLC (NYSE: ARDT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $24.00 price target on the stock.
Ardent Health Partners, Inc. (ARDT)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
ARDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDT alerts
High impacting Ardent Health Partners, Inc. news events
Weekly update
A roundup of the hottest topics
ARDT
News
- Nine Ardent Health Facilities Earn “A” Hospital Safety Grade From The Leapfrog GroupBusiness Wire
- Ardent Health Partners, LLC (NYSE: ARDT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.MarketBeat
- Ardent Health Partners, LLC (NYSE: ARDT) had its price target raised by analysts at Leerink Partners from $23.00 to $25.00. They now have an "outperform" rating on the stock.MarketBeat
- Ardent Health Reports Third Quarter 2024 ResultsBusiness Wire
- Ardent Health Partners, LLC (NYSE: ARDT) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $19.00 price target on the stock, down previously from $22.00.MarketBeat
ARDT
Earnings
- 11/6/24 - Miss
ARDT
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- ARDT's page on the SEC website